Podcast: Download (Duration: 7:25 — 6.8MB)
Subscribe: RSS
In this podcast, Nadine Rosenblum and Maddie Whalen meet to discuss spam email that appears to be an authentic journal, but which may not be. They discuss how to identify a likely spam email and reasons why a recent submission …
Ep34 Journal Spam | Johns Hopkins Center for Nursing Inquiry Read more »
Podcast: Download (Duration: 7:03 — 6.5MB)
Subscribe: RSS
In this podcast, Nadine Rosenblum and Maddie Whalen meet to the difference between resumes and curriculum vitae or (CVs). They define, contrast and compare the two, and discuss when to use which type of document. They wrap up the discussion …
Ep33 Resumes vs CVs | Johns Hopkins Center for Nursing Inquiry Read more »
Podcast: Download (Duration: 13:19 — 12.2MB)
Subscribe: RSS
In this podcast, Nadine Rosenblum and Nurse Scientist Heather Watson meet to continue the discussion about the Institutional Review Board. They discuss types of IRB applications, stakeholders to include, training for study team participation and other requirements for submitting an …
Ep32 IRB 201 | Johns Hopkins Center for Nursing Inquiry Read more »
Podcast: Download (Duration: 13:05 — 12.0MB)
Subscribe: RSS
In this podcast, Nadine Rosenblum and Nurse Scientist Heather Watson meet to talk about the Institutional Review Board. They discuss the types of projects that need IRB approval. They also discuss what role a Principal Investigator plays, as well as …
Ep31 IRB 101 | Johns Hopkins Center for Nursing Inquiry Read more »
Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
Variants of Covid are springing up all the time, perhaps in people who have compromised immune systems and experience prolonged infection or in animal hosts. Stuart Ray, an infectious disease expert at Johns Hopkins, says right now with Delta and …
Omicron is not the last Covid variant, Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Both vaccine developers and the FDA have agreed that as new Covid variants emerge and updated vaccines are required, the pathway for providing them should involve testing in far fewer people and over a shorter period of time. Jonathan Zenilman, …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Why aren’t Covid vaccines, especially mRNA vaccines, being produced against variants such as Omicron as they emerge? Anna Durbin, an infectious disease expert at Johns Hopkins, says this is what the technology promises. Durbin: I do think we have to …
